1. ALLA AKTIER
  2. NYHETER
  3. GUARD THERAPEUTICS

Guard Therapeutics

Nyheter Guard Therapeutics Nyheter alla bolag
eToro Trading Platform Advertisement
Slipp dessa annonser och få en massa andra godsaker med vårt premiumabonnemang.

Guard Therapeutics changes Certified Adviser to Redeye AB

MARKN.

Guard Therapeutics (publ) has entered into an agreement with Redeye AB regarding the service as Certified Adviser. Redeye AB will assume the role of Certified Adviser on 8 December 2025.

For further information, please contact:

Tobias Agervald, CEO
Telephone: +46 8 670 65 51
E-mail: info@guardtherapeutics.com 

About Guard Therapeutics

Guard Therapeutics is a Swedish clinical-stage biotechnology company that identifies and develops new therapies for diseases with a large unmet medical need, focusing on different forms of kidney disease. The company’s candidate drugs are based on the endogenous protein alpha-1-microglobulin. Guard Therapeutics is listed on Nasdaq First North Growth Market Stockholm (ticker: GUARD).

Certified Adviser is Svensk Kapitalmarknadsgranskning AB, www.skmg.se.

Attachments

Guard Therapeutics changes Certified Adviser to Redeye AB

Datum 2025-12-05, kl 14:40
Källa MFN
Bifogade filer
Guard Therapeutics changes Certified Adviser to Redeye AB